A new study links the virus that causes chickenpox and shingles to a condition that inflames blood vessels on the temples and scalp in the elderly, called giant cell arteritis. The study is published in the Feb. 18 online issue of Neurology, the medical journal of the American Academy of Neurology. The condition can cause sudden blindness or stroke and can be life-threatening.
The varicella zoster virus, of the herpes virus family, can cause chicken pox and may reactivate later in life in the form of shingles, a very painful rash.
“Our analysis, which is the largest to-date, provides compelling evidence that the virus also reactivates in people over 60 in another way, triggering giant cell arteritis,” says study author Don Gilden, MD, professor of neurology at the University of Colorado School of Medicine in Denver and a fellow of the American Academy of Neurology.
Giant cell arteritis causes swelling and tenderness of the arteries on the scalp and temples of people over the age of 50. Gilden notes that it is the most common type of inflammation of blood vessels in the elderly, affecting an estimated 29 out of 100,000 people. Symptoms include a new severe headache, scalp tenderness, jaw discomfort, blurred vision, fever, weight loss and tiredness. Importantly, the cause of this condition has been uncertain, prompting the present study.
For the study, researchers searched for evidence of the virus in 13 temporal artery biopsies of people who died and had no previous symptoms of giant cell arteritis and in 84 temporal artery biopsies of people with giant cell arteritis. All of the biopsies were from people over the age of 50.
The virus was found in 74 percent of the biopsies with giant cell arteritis and in only 8 percent of the normal skin biopsies.
“If the association can be replicated in other studies, clinical trials should focus on treating people with giant cell arteritis with a combination of the current steroid drugs used for the condition, plus anti-viral treatment for the virus,” says Gilden.
The study was supported by the National Institutes of Health.
Source: American Academy of Neurology
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.